Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Submitted by
admin
on April 2, 2009 - 8:00am
Source:
Seeking Alpha
News Tags:
biotech
Acorda Therapeutics
CV Therapeutics
Arena Pharmaceuticals
Genentech
Gilead Sciences
ZymoGenetics
ViroPharma
MAP Pharmaceuticals
Synta
La Jolla Pharmaceutical
Indevus
InterMune
Osiris Therapeutics
Headline:
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Do Not Allow Advertisers to Use My Personal information
